PuSH - Publikationsserver des Helmholtz Zentrums München

38 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Jesinghaus, M.* et al.: Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma. Br. J. Cancer 122, 835-846 (2020)
Jesinghaus, M.* et al.: Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma. Br. J. Cancer 121, 1050-1057 (2019)
Summerer, I. et al.: Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br. J. Cancer 113, 76-82 (2015)
Malinowsky, K.* et al.: Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br. J. Cancer 110, 2081-2089 (2014)
Wyler, L.* et al.: Brain metastasis in renal cancer patients: Metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br. J. Cancer 110, 686-694 (2014)
Enciso-Mora, V.* et al.: Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br. J. Cancer 108, 2178-2185 (2013)
Falkenberg, N. et al.: MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion. Br. J. Cancer 109, 2714-2723 (2013)
Gross, E.* et al.: Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. Br. J. Cancer 109, 2347-2355 (2013)
Rohrmann, S.* et al.: Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br. J. Cancer 108, 708-714 (2013)
Slotta-Huspenina, J.* et al.: A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br. J. Cancer 109, 370-378 (2013)
Buck, K.* et al.: Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br. J. Cancer 105, 1151-1157 (2011)
Aubele, M. et al.: In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br. J. Cancer 103, 663-667 (2010)
Mallett, S.* ; Timmer, A. ; Sauerbrei, W.* & Altman, D.G.*: Reporting of prognostic studies of tumour markers: A review of published articles in relation to REMARK guidelines. Br. J. Cancer 102, 173-180 (2010)
Horsch, M. et al.: Overexpressed vs mutated Kras in murine fibroblasts: A molecular phenotyping study. Br. J. Cancer 100, 656-662 (2009)
Stumpf, M.* et al.: Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: Relevance of clonal selection of T lymphocytes. Br. J. Cancer 101, 1513-1521 (2009)
Aubele, M. et al.: Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 99, 1089-1095 (2008)
Blechschmidt, K.* et al.: The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br. J. Cancer 98, 489-495 (2008)
Hennig, R.* et al.: BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer 99, 1064-1073 (2008)
Atmaca, A.* et al.: Valproic acid (VPA) in patients with refractory advanced cancer: A dose escalating phase I clinical trial. Br. J. Cancer 97, 177-182 (2007)
Aubele, M. et al.: PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br. J. Cancer 96, 801-807 (2007)